Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.

    Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ.

    Diabetes Care. 2009 Apr;32(4):708-13. Epub 2008 Dec 29.PMID: 19114615 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.

    Metcalf PA, Wells S, Scragg RK, Jackson R.

    N Z Med J. 2008 Sep 5;121(1281):49-57.PMID: 18797484 [PubMed - indexed for MEDLINE]Related articles

    5.

    Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.

    Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ; European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.

    Int J Epidemiol. 2004 Feb;33(1):189-98.PMID: 15075168 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.

    Price HC, Coleman RL, Stevens RJ, Holman RR.

    Diabetologia. 2009 Mar;52(3):394-7. Epub 2008 Dec 2.PMID: 19048226 [PubMed - indexed for MEDLINE]Related articles

    7.

    Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.

    Whitfield MD, Gillett M, Holmes M, Ogden E.

    Public Health. 2006 Dec;120(12):1140-8. Epub 2006 Nov 3.PMID: 17084425 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.

    Game FL, Bartlett WA, Bayly GR, Jones AF.

    Diabetes Obes Metab. 2001 Aug;3(4):279-86.PMID: 11520308 [PubMed - indexed for MEDLINE]Related articles

    9.

    Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

    Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P.

    BMJ. 2007 Jul 21;335(7611):136. Epub 2007 Jul 5.PMID: 17615182 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

    Simmons RK, Sharp S, Boekholdt SM, Sargeant LA, Khaw KT, Wareham NJ, Griffin SJ.

    Arch Intern Med. 2008 Jun 9;168(11):1209-16.PMID: 18541829 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.

    Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ.

    Diabetologia. 2009 May;52(5):789-97. Epub 2009 Mar 10.PMID: 19274450 [PubMed - indexed for MEDLINE]Related articles

    12.

    Is hyperglycemia associated with cardiovascular disease? The Framingham Study.

    Wilson PW, Cupples LA, Kannel WB.

    Am Heart J. 1991 Feb;121(2 Pt 1):586-90.PMID: 1990765 [PubMed - indexed for MEDLINE]Related articles

    14.

    Deficiencies of cardiovascular risk prediction models for type 1 diabetes.

    Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS.

    Diabetes Care. 2006 Aug;29(8):1860-5.PMID: 16873793 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.

    Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P.

    Heart. 2008 Jan;94(1):34-9. Epub 2007 Oct 4.PMID: 17916661 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.

    Fox CS, Coady S, Sorlie PD, D'Agostino RB Sr, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ.

    Circulation. 2007 Mar 27;115(12):1544-50. Epub 2007 Mar 12.PMID: 17353438 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.

    Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study.

    Diabetes Care. 2002 Oct;25(10):1845-50.PMID: 12351489 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.

    Preis SR, Pencina MJ, Hwang SJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS.

    Circulation. 2009 Jul 21;120(3):212-20. Epub 2009 Jul 6.PMID: 19581493 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study.

    Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB Sr.

    Diabetes Care. 2008 Aug;31(8):1582-4. Epub 2008 May 5.PMID: 18458146 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

    Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N.

    Ann Intern Med. 2004 Sep 21;141(6):413-20.PMID: 15381514 [PubMed - indexed for MEDLINE]Related articlesFree article